Thursday, November 15, 2007


Topical bromfenac effective in improving vision in CME patients

According to this paper:

Administering topical Xibrom (bromfenac ophthalmic solution 0.09%, Ista Pharmaceuticals) twice daily is as effective as diclofenac sodium and ketorolac tromethamine for the treatment of acute pseudophakic CME after uncomplicated phacoemulsification and posterior chamber IOL implantation.

No comments:

Post a Comment

Leave a Comment or Question: